Literature DB >> 9046251

The incidence of primary angle-closure glaucoma in Olmsted County, Minnesota.

J C Erie1, D O Hodge, D T Gray.   

Abstract

OBJECTIVES: To determine the incidence of primary angle-closure glaucoma (PACG) and to assess the visual outcomes of patients treated for PACG.
DESIGN: Population-based retrospective incidence study. SETTING AND PATIENTS: Residents of Olmsted County, Minnesota, aged 40 years and older and diagnosed with PACG in the 13-year period between January 1, 1980, and December 31, 1992. MAIN OUTCOME MEASURE: Incident cases of PACG identified through the Medical Diagnostic Index of Mayo Clinic, Rochester, Minn, and the Rochester Epidemiology Project.
RESULTS: Thirty-six incident cases were identified. The mean annual age-and sex-adjusted incidence per 100000 people aged 40 years and older was 8.3 (95% confidence interval, 5.6-11.0). The probability of monocular blindness associated with PACG at the time of diagnosis was 14%. Among patients not monocularly blind at diagnosis, the 5-year probability of developing monocular blindness associated with PACG was 4%.
CONCLUSIONS: Primary angle-closure glaucoma is an uncommon disease in our community. Most of the patients blinded by PACG were blind at the time the condition was diagnosed.

Entities:  

Mesh:

Year:  1997        PMID: 9046251     DOI: 10.1001/archopht.1997.01100150179005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  14 in total

Review 1.  The definition and classification of glaucoma in prevalence surveys.

Authors:  Paul J Foster; Ralf Buhrmann; Harry A Quigley; Gordon J Johnson
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Early lens extraction compared to standard treatment in acute primary angle closure.

Authors:  Dolly S Chang; Eugenio Maul; David Friedman
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 3.  [Primary phacoemulsification following acute primary angle closure glaucoma].

Authors:  P C Jacobi
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

4.  Changes in anterior segment morphology in response to illumination and after laser iridotomy in Asian eyes: an anterior segment OCT study.

Authors:  Jovina L S See; Paul T K Chew; Scott D Smith; Winifred P Nolan; Yiong-Huak Chan; David Huang; Ce Zheng; Paul J Foster; Tin Aung; David S Friedman
Journal:  Br J Ophthalmol       Date:  2007-05-15       Impact factor: 4.638

5.  Iridotomy to slow progression of angle-closure glaucoma.

Authors:  Jimmy T Le; Benjamin Rouse; Gus Gazzard
Journal:  Cochrane Database Syst Rev       Date:  2016-06-29

6.  Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial.

Authors:  Benjamin Y Xu; David S Friedman; Paul J Foster; Yu Jiang; Natalia Porporato; Anmol A Pardeshi; Yuzhen Jiang; Beatriz Munoz; Tin Aung; Mingguang He
Journal:  Ophthalmology       Date:  2021-10-08       Impact factor: 12.079

7.  Association of Vitamin D deficiency with primary glaucoma among Saudi population - A pilot study.

Authors:  Kholoud A Bokhary; Loujain Y Alqahtani; Feda S Aljaser; Manal Abudawood; Faisal Almubarak; Shatha Algowaifly; Khalid F Jamous; Rania Fahmy
Journal:  Saudi J Ophthalmol       Date:  2022-06-13

8.  Reply.

Authors:  Louis R Pasquale; Leslie Hyman; Janey L Wiggs; Bernard A Rosner; Kaumudi Joshipura; Mark McEvoy; Zachary E McPherson; John Danias; Jae H Kang
Journal:  Ophthalmology       Date:  2017-05       Impact factor: 12.079

9.  Quantitative evaluation of changes in anterior segment biometry by peripheral laser iridotomy using newly developed scanning peripheral anterior chamber depth analyser.

Authors:  K Kashiwagi; K Abe; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

Review 10.  Angle imaging: advances and challenges.

Authors:  Desmond T L Quek; Monisha E Nongpiur; Shamira A Perera; Tin Aung
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.